Immunonutrition in the surgical patient

Minerva Anestesiologica

Volumn 78, Issue 3, 2012, Pages 336-341

  Marik, P E ^a   Flemmer, M ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Arginase; Arginine; Fatty acids; Immunosuppression; Omega 3; Operative; Surgical procedures

Indexed keywords

ARGINASE 1; ARGININE; CATECHOLAMINE DERIVATIVE; HLA DR ANTIGEN; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; ELECTIVE SURGERY; ENTERIC FEEDING; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; NATURAL KILLER CELL; NUTRITIONAL SUPPORT; POSTOPERATIVE PERIOD; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; REVIEW; SEPSIS; SUPPRESSOR CELL; SURGICAL PATIENT; SURGICAL TECHNIQUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TH1 CELL; TH2 CELL;

ARGINASE; ARGININE; CATECHOLAMINES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DINOPROSTONE; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; FOOD, FORMULATED; HUMANS; HYDROCORTISONE; IMMUNITY, CELLULAR; INFLAMMATION; MALNUTRITION; META-ANALYSIS AS TOPIC; NUTRITIONAL SUPPORT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TH2 CELLS; WOUNDS AND INJURIES;

EID: 84857555858     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Stundley H O. Percentage of weight loss. A basic indicator of surgical risk in patients with chronic peptic ulcer. JAMA 1939; 106: 458-460.
2. Barker LA, Gout BS, Crowe TC. Hospital malnutrition: prevalence, identification and impact on patients and the healthcare system. Int J Environ Res Public H ealth 2011; 8: 514-527.
3. Somanchi M, Tao X, Mullin GE. The facilitated earlyteral and dietary management effectiveness trial in hospitalized patients with malnutrition. JPEN 2011; 35: 206-219.
4. Pirlich M, Schütz T, Norman K, Gastell S, Lübke H J, Bischoff S et al. The German hospital malnutrition study. Clinical Nutrition 2006; 25: 563-572.
5. Nájera O, González C, Toledo G, López L, Ortiz R. Flow cytometry study of lymphocyte subsets in malnourished and well-nourished children with bacterial infections. Clin Diagn Lab Immunol 2004; 11: 577-580.
6. Enwonwu CO, Phillips RS, Savage KO. Inflammatory cytokine profile and circulating cortisol levels in malnourished children with necrotizing ulcerative gingivitis. European Cytokine Network 2005; 16: 240-248.
7. Rodriguez L, González C, Flores L, Jiménez-Zamudio L, Graniel J, Ortiz R. Assessment by flow cytometry of cytokine production in malnourished children. Clin Diagn Lab Immunol 2005; 12: 502-507.
8. Siddiqui RA, Shaikh SR, Sech LA, Yount H R, Stillwell W, Zaloga GP. Omega 3-fatty acids: health benefits and cellular mechanisms of action. Mini Rev Med Chem 2004; 4: 859-871.
9. Vermeulen MA, van de Poll MC, Ligthart-Melis GC, Dejong CH, van den Tol MP, Boelens PG et al. Specific amino acids in the critically ill patient--exogenous glutamine/arginine: a common denominator? Crit Care Med 2007;35: S568-S576.
10. Mayer K, Seeger W. Fish oil in critical illness. Curr Opin Clin Nutr Metab Care 2008; 11: 121-127.
11. Zaloga GP, Siddiqui RA. Biologically active dietary peptides. Mini Rev Med Chem 2004; 4: 815-821.
12. Mizock BA. Immunonutrition and critical illness: an update. Nutrition 2010; 26: 701-707.
13. Montejo JC, Zarazaga A, López-Martínez J, Urrútia G, Roqué M, Blesa AL et al. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clinical Nutrition 2003; 22: 221-233.
14. Grimble RF. Immunonutrition. Curr Opin Gastroenterol 2005; 21: 216-222.
15. Zhou M, Martindale RG. Immune-modulating enteral formulations: optimum components, appropriate patients, and controversial use of arginine in sepsis. Curr Gastroenterol Rep 2007; 9: 329-337.
16. Elenkov IJ. Systemic stress-induced Th2 shift and its clinical implications. Int Rev Neurobiol 2002;52:163-186.
17. Blotta MH, DeKruyff RH, Umetsu DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997; 158: 5589-5595.
18. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 2004;1024:138-46.
19. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg 2001;193: 237-244.
20. Keel M, Trentz O. Pathophysiology of polytrauma. Injury 2005; 36: 691-709.
21. Roumen RM, H endriks T, van der Ven-Jongekrijg J, Nieuwenhuijzen GA, Sauerwein RW et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993; 218: 769-776.
22. Wortel CH, van Deventer SJ, Aarden LA, Lygidakis NJ, Büller H R, Hoek FJ et al. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery 1993;114: 564-570.
23. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock 1999;11: 153-159.
24. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA. Surgical stress induces a shift in the type-1/ type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996;119: 316-325.
25. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin- 12 production associated with decreased resistance to infection. Ann Surg 1995; 222: 482-490.
26. Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T et al. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med 2003; 31: 1722-1729.
27. Lendemans S, Kreuzfelder E, Rani M, Bayeeh E, Schade FU, Flohé S et al. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system. J Trauma 2007; 63: 740-746.
28. Kirchhoff C, Biberthaler P, Mutschler WE, Faist E, Jochum M, Zedler S. Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a cohort study. Crit Care 2009; 13: R88.
29. Duggan E, Caraher E, Gately K, O'Dwyer M, McGovern E, Kelleher D et al. Tumor necrosis factor-alpha and interleukin- 10 gene expression in peripheral blood mononuclear cells after cardiac surgery. Crit Care Med 2006; 34: 2134-2139.
30. Elenkov IJ, Chrousos GP. Stress system--organization, physiology and immunoregulation. Neuroimmunomodulation 2006; 13: 257-267.
31. Ochoa JB, Bernard AC, O'Brien WE, Griffen MM, Maley ME, Rockich AK et al. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg 2001; 233: 393-399
32. Zhu X, Herrera G, Ochoa JB. Immunosupression and infection after major surgery: A nutritional deficiency. Crit Care Clin 2010; 26: 491-500.
33. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936; 136: 132.
34. Marik PE. Critical illness related corticoseroid insufficiency. Chest 2009; 135: 181-193.
35. Wing K, Suri-Payer E, Rudin A. CD4+ cd25+ regulatory T cells from mouse to man. Scand J Immunol 2005; 62: 1-15.
36. MacConmara MP, Maung AA, Fujimi S, McKenna AM, Delisle A, Lapchak PH et al. Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 2006; 244: 514-523.
37. Chiarla C, Giovannini I, Siegel JH. Plasma arginine correlations in trauma and sepsis. Amino Acids 2006; 30: 81-86.
38. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons R et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214: 621-626.
39. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41: 77-81.
40. Kilbourn RG, Griffith OW. Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 1992; 84: 827-831.
41. Jacob TD, Ochoa JB, Udekwu AO, Wilkinson J, Murray T, Billiar TR et al. Nitric oxide production is inhibited in trauma patients. J Trauma 1993; 35: 590-596.
42. Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 2006; 176: 2085-2094.
43. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nature 2009; 9: 162-174.
44. Barksdale AR, Bernard AC, Maley ME, Gellin GL, Kearney PA, Boulanger BR et al. Regulation of arginase expression by T-helper II cytokines and isoproterenol. Surgery 2004; 135: 527-535.
45. Bernard AC, Fitzpatrick EA, Maley ME, Gellin GL, Tsuei BJ, Arden WA et al. Beta adrenoceptor regulation of macrophage arginase activity. Surgery 2000; 127: 412-418.
46. Rodriguez PC, H ernandez CP, Quiceno D, Dubinett SM, Zabaleta J, Ochoa JB et al. Arginase I in myeloid suppressorcells is induced by COX-2 in lung carcinoma. J Exp Med 2005; 202: 931-939.
47. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007; 28: 176-183.
48. Witte MB, Barbul A. Arginine physiology and its implication for wound healing. Wound Repair Regen 2003; 11: 419-423.
49. Zaloga GP, Siddiqui R, Terry C, Marik PE. Arginine: mediator or modulator of sepsis? Nutr Clin Pract 2004; 19: 201-215.
50. Popovic PJ, Zeh H J, III, Ochoa JB. Arginine and immunity. J Nutr 2007;137: 1681S-1686S.
51. Lovett JE, III, Fink BF, Bernard A, Ochoa J. Analysis of nitric oxide activity in prevention of reperfusion injury. Ann Plast Surg 2001; 46: 269-273.
52. Tepaske R, Velthuis H, Oudemans van Straaten H M, Heisterkamp SH, van Deventer SJ, Ince C et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 2001; 358: 696-701.
53. Daly JM, Lieberman MD, Goldfine J, Shou J, Weintraub F, Rosato EF et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992; 112: 56-67.
54. Moore FA, Moore EE, Kudsk KA, Brown RO, Bower RH, Koruda MJ et al. Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma 1994; 37: 607-615.
55. Cerra FB, Lehman S, Konstantinides N, Konstantinides F, Shronts EP, Holman R et al. Effect of enteral nutrient on in vitro tests of immune function in ICU patients: a preliminary report. Nutrition 1990; 6: 84-87.
56. Daly JM, Reynolds J, Thom A, Kinsley L, Dietrick-Gallagher M, Shou J et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208: 512-523.
57. Wu GH, Zhang YW, Wu ZH. Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients. World Journal of Gastroenterology 2001; 7: 357-362.
58. Matsuda A, Furukawa K, Takasaki H, Suzuki H, Kan H, Tsuruta H et al. Preoperative oral immune-enhancing nutritional supplementation corrects TH1/TH2 imbalance in patients undergoing elective surgery for colorectal cancer. Dis Col Rect 2006; 49: 507-516.
59. Farreras N, Artigas V, Cardona D, Rius X, Trias M, González JA. Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clinical Nutrition 2005; 24: 55-65.
60. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999; 229: 467-477.
61. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999; 27: 2799-2805.
62. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286: 944-953.
63. Marik PE, Zaloga GP. Immunonutrition in high risk surgical patients: A systematic review and analysis of the literature. JPEN 2010; 34: 378-386.
64. Drover JW, Dhaliwal R, Weitzel L, Wischmeyer PE, Ochoa JB, H eyland DK. Perioperative use of arginine-supplemented diets: a systematic review of the evidence. J Am Coll Surg 2011; 212: 385-399.
65. Atkinson S, Sieffert E, Bihari D. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy's H ospital Intensive Care Group. Crit Care Med 1998; 26: 1164-1172.
66. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999; 27: 1409-1420.
67. Gianotti L, Braga M, Fortis C, Soldini L, Vignali A, Colombo S et al. A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional status. JPEN 1999; 23: 314-320.
68. Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002; 137: 174-180.
69. Giger U, Buchler M, Farhadi J, Berger D, H üsler J, Schneider H et al. Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncol 2007;14: 2798-2806.
70. Weimann A, Braga M, Harsanyi L, Laviano A, Ljungqvist O, Soeters P et al. ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clinical Nutrition 2006; 25: 224-244.
71. Braga M, Gianotti L. Preoperative immunonutrition:Costbenefit analysis. JPEN 2005; 29: S57-S61.
72. Gianotti L, Braga M, Frei A, Greiner R, Di Carlo V. H ealth care resources consumed to treat postoperative infections: cost saving by perioperative immu nonutrition. Shock 2000; 14: 325-330.